ACE and hypertensive disorder: In the control group, angiotensin-​converting enzyme (ACE)/ Angiotensin Receptor Blocker (ARB) use, HTN, and receiving MV were factors significantly associated with in-hospital mortality, and statin use was significantly related to a lower rate of adverse outcomes (death, MV, and ICU care) (Table 5).